Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:JNJNASDAQ:MUNASDAQ:UTHRNASDAQ:WING On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeJNJJohnson & Johnson$155.57-0.2%$153.63$140.68▼$169.99$375.15B0.418.01 million shs5.54 million shsMUMicron Technology$122.34+1.2%$101.83$61.54▼$137.13$135.29B1.3523.25 million shs29.26 million shsUTHRUnited Therapeutics$295.65+1.6%$301.18$266.98▼$417.82$13.12B0.53443,913 shs401,875 shsWINGWingstop$325.66-2.9%$320.74$204.00▼$433.86$9.36B1.84650,436 shs702,926 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceJNJJohnson & Johnson-0.14%+2.14%+0.14%-2.69%+6.55%MUMicron Technology+0.70%-4.33%+24.00%+63.76%-8.18%UTHRUnited Therapeutics+1.48%+3.23%-9.30%-3.95%-6.89%WINGWingstop-2.73%-8.37%-6.53%+34.40%-22.46%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationJNJJohnson & Johnson4.8551 of 5 stars2.35.04.23.93.11.71.9MUMicron Technology4.9507 of 5 stars3.45.01.71.83.32.53.1UTHRUnited Therapeutics4.9949 of 5 stars4.35.00.04.63.43.32.5WINGWingstop3.8904 of 5 stars3.44.02.50.02.00.81.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceJNJJohnson & Johnson 2.55Moderate Buy$170.889.84% UpsideMUMicron Technology 2.83Moderate Buy$146.2119.51% UpsideUTHRUnited Therapeutics 2.69Moderate Buy$386.1530.61% UpsideWINGWingstop 2.80Moderate Buy$362.2611.24% UpsideCurrent Analyst Ratings BreakdownLatest JNJ, MU, WING, and UTHR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/30/2025UTHRUnited TherapeuticsUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$410.00 ➝ $385.006/27/2025MUMicron TechnologyRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$163.00 ➝ $200.006/26/2025WINGWingstopBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$360.00 ➝ $410.006/26/2025MUMicron TechnologyWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$150.00 ➝ $165.006/26/2025MUMicron TechnologyCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$145.00 ➝ $155.006/26/2025MUMicron TechnologyRaymond James FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$120.00 ➝ $150.006/26/2025MUMicron TechnologyMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$98.00 ➝ $135.006/26/2025MUMicron TechnologySusquehannaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetPositive ➝ Positive$150.00 ➝ $160.006/26/2025MUMicron TechnologyPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$120.00 ➝ $165.006/26/2025MUMicron TechnologyBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$84.00 ➝ $140.006/26/2025MUMicron TechnologyWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$150.00 ➝ $170.00(Data available from 7/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookJNJJohnson & Johnson$88.82B4.21$13.10 per share11.88$29.69 per share5.24MUMicron Technology$25.11B5.45$7.69 per share15.90$45.35 per share2.70UTHRUnited Therapeutics$2.88B4.63$28.84 per share10.25$144.34 per share2.05WINGWingstop$625.81M14.52$4.30 per share75.78($23.13) per share-14.08Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateJNJJohnson & Johnson$14.07B$8.9917.3014.052.3624.42%33.46%13.30%7/16/2025 (Estimated)MUMicron Technology$778M$4.1721.9411.47N/A18.41%13.60%8.90%N/AUTHRUnited Therapeutics$1.20B$25.0611.8010.756.3740.44%19.33%16.73%7/30/2025 (Estimated)WINGWingstop$108.72M$5.9754.6664.234.6926.45%-18.85%18.26%7/30/2025 (Estimated)Latest JNJ, MU, WING, and UTHR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/30/2025Q2 2025UTHRUnited Therapeutics$6.89N/AN/AN/A$802.13 millionN/A7/30/2025Q2 2025WINGWingstop$0.87N/AN/AN/A$172.60 millionN/A7/16/2025Q2 2025JNJJohnson & Johnson$2.65N/AN/AN/A$22.85 billionN/A6/25/2025Q3 2025MUMicron Technology$1.57$1.91+$0.34$1.68$8.83 billion$9.30 billion4/30/2025Q1 2025UTHRUnited Therapeutics$6.29$6.63+$0.34$6.63$726.82 million$794.40 million4/30/2025Q1 2025WINGWingstop$0.84$0.99+$0.15$3.24$172.25 million$171.09 million4/15/2025Q1 2025JNJJohnson & Johnson$2.59$2.77+$0.18$4.54$21.65 billion$21.89 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthJNJJohnson & Johnson$5.203.34%N/A57.84%64 YearsMUMicron Technology$0.460.38%N/A11.03%N/AUTHRUnited TherapeuticsN/AN/AN/AN/AN/AWINGWingstop$1.080.33%N/A18.09%7 YearsLatest JNJ, MU, WING, and UTHR DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/25/2025MUMicron Technologyquarterly$0.11500.4%7/7/20257/7/20257/22/20254/15/2025JNJJohnson & Johnsonquarterly$1.303.37%5/27/20255/27/20256/10/20254/29/2025WINGWingstopquarterly$0.270.4%5/16/20255/16/20256/6/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioJNJJohnson & Johnson0.491.261.03MUMicron Technology0.302.751.89UTHRUnited TherapeuticsN/A5.465.23WINGWingstopN/A3.563.56Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipJNJJohnson & Johnson69.55%MUMicron Technology80.84%UTHRUnited Therapeutics94.08%WINGWingstopN/AInsider OwnershipCompanyInsider OwnershipJNJJohnson & Johnson0.16%MUMicron Technology0.30%UTHRUnited Therapeutics10.30%WINGWingstop0.72%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableJNJJohnson & Johnson138,1002.41 billion2.40 billionOptionableMUMicron Technology48,0001.12 billion1.12 billionOptionableUTHRUnited Therapeutics1,30545.11 million40.46 millionOptionableWINGWingstop1,33527.90 million27.70 millionOptionableJNJ, MU, WING, and UTHR HeadlinesRecent News About These CompaniesWingstop (WING) Receives a Buy from BTIGJuly 3 at 2:45 AM | theglobeandmail.comWingstop Hickory Smoked BBQ Chicken Sandwich Review Smoky And SatisfyingJuly 3 at 2:45 AM | msn.comWingstop (WING) Stock Slides as Market Rises: Facts to Know Before You TradeJuly 2 at 7:01 PM | zacks.comAre Wingstop and Five Guys still opening in Eau Claire?July 2 at 4:43 PM | wqow.comWWingstop (NASDAQ:WING) Trading Down 5.2% - Time to Sell?July 2 at 3:23 PM | marketbeat.comIs Wingstop on the Verge of Another Sales Tear?July 2 at 11:43 AM | qsrmagazine.comQWingstop Mango Habanero Chicken Sandwich Review Sweet Heat PerfectionJuly 2 at 11:43 AM | msn.comAmerican fast food chain Wingstop set to come to CoventryJuly 1 at 12:37 PM | msn.comWingstop Inc. to Announce Fiscal Second Quarter 2025 Financial Results on July 30, 2025July 1 at 8:00 AM | prnewswire.comWingstop Inc. (NASDAQ:WING) Shares Sold by Allspring Global Investments Holdings LLCJuly 1 at 4:48 AM | marketbeat.comPlymouth Wingstop opens today with free chicken wings for first 100 customersJune 30 at 6:27 AM | uk.news.yahoo.comPlans revealed for chicken restaurant chain Wingstop to open in PrestonJune 29, 2025 | msn.comDiversified Trust Co Has $1.01 Million Stock Holdings in Wingstop Inc. (NASDAQ:WING)June 29, 2025 | marketbeat.comWingstop Inc. (NASDAQ:WING) Shares Acquired by Oppenheimer Asset Management Inc.June 29, 2025 | marketbeat.comCopeland Capital Management LLC Trims Stock Position in Wingstop Inc. (NASDAQ:WING)June 28, 2025 | marketbeat.comWingstop UK crowned fastest growing restaurant group in the UK for third year running by The Sunday Times 100June 27, 2025 | retailtimes.co.ukRWingstop’s NBA partnership wins over chicken fansJune 27, 2025 | wattagnet.comWBessemer Group Inc. Reduces Position in Wingstop Inc. (NASDAQ:WING)June 27, 2025 | marketbeat.comSG Americas Securities LLC Trims Position in Wingstop Inc. (NASDAQ:WING)June 27, 2025 | marketbeat.comTop 10 poultry consumer trends of 2025 (so far)June 26, 2025 | wattagnet.comWWingstop (NASDAQ:WING) Stock Price Down 3.7% - Here's WhyJune 26, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Semiconductor Stocks Poised to Surge on AI SpendingBy Chris Markoch | June 25, 2025View 3 Semiconductor Stocks Poised to Surge on AI SpendingAST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap!By Thomas Hughes | June 16, 2025View AST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap!Addition by Subtraction: Intel’s New Strategy Energizes InvestorsBy Jeffrey Neal Johnson | June 27, 2025View Addition by Subtraction: Intel’s New Strategy Energizes InvestorsWhy Qualcomm’s Latest Price Target Can't Be IgnoredBy Sam Quirke | June 24, 2025View Why Qualcomm’s Latest Price Target Can't Be IgnoredRKLB Breakout Fails Near Highs: Should Investors Be Concerned?By Ryan Hasson | June 11, 2025View RKLB Breakout Fails Near Highs: Should Investors Be Concerned?JNJ, MU, WING, and UTHR Company DescriptionsJohnson & Johnson NYSE:JNJ$155.57 -0.35 (-0.23%) As of 09:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.Micron Technology NASDAQ:MU$122.34 +1.45 (+1.20%) As of 09:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Micron Technology, Inc. designs, develops, manufactures, and sells memory and storage products worldwide. The company operates through four segments: Compute and Networking Business Unit, Mobile Business Unit, Embedded Business Unit, and Storage Business Unit. It provides memory and storage technologies comprising dynamic random access memory semiconductor devices with low latency that provide high-speed data retrieval; non-volatile and re-writeable semiconductor storage devices; and non-volatile re-writable semiconductor memory devices that provide fast read speeds under the Micron and Crucial brands, as well as through private labels. The company offers memory products for the cloud server, enterprise, client, graphics, networking, industrial, and automotive markets, as well as for smartphone and other mobile-device markets; SSDs and component-level solutions for the enterprise and cloud, client, and consumer storage markets; discrete storage products in component and wafers; and memory and storage products for the automotive, industrial, and consumer markets. It markets its products through its direct sales force, independent sales representatives, distributors, and retailers; and web-based customer direct sales channel, as well as through channel and distribution partners. Micron Technology, Inc. was founded in 1978 and is headquartered in Boise, Idaho.United Therapeutics NASDAQ:UTHR$295.65 +4.74 (+1.63%) As of 09:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for treating high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, the company engages in developing RemoPro and Ralinepag for the treatment of PAH; Aurora-GT, a gene therapy product to rebuild the blood vessels in the lungs; and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.Wingstop NASDAQ:WING$325.66 -9.79 (-2.92%) As of 09:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Wingstop Inc., together with its subsidiaries, franchises and operates restaurants under the Wingstop brand. Its restaurants offer classic wings, boneless wings, tenders, and hand-sauced-and-tossed in various flavors, as well as chicken sandwiches with fries and hand-cut carrots and celery that are cooked-to-order. The company was founded in 1994 and is headquartered in Addison, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Rocket Lab: Latest Catalysts Bolster the Bull Case Nike's Stock Just Got an Upgrade: Is a Real Comeback Brewing? Jefferies Raises Broadcom Price Target to $315: 19% Upside Ahead Dan Ives’ Bold $5 Trillion Forecast for Microsoft Stock 3 Utility Stocks That Combine Income and Stability 2 Reasons to Buy Trade Desk Stock Now and 1 Warning Sign Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
